Prediction of Adverse Cardiovascular Events of Noncardiovascular Drugs through Drug-Target Interaction Networks

Clinical and Translational Science

Volumn 5, Issue 1, 2012, Pages 111-

  Azuaje, Francisco J ^a   Devaux, Yvan ^a   Wagner, Daniel R ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; ROSIGLITAZONE; VARENICLINE;

ADVERSE DRUG REACTION; CARDIOVASCULAR DISEASE; DRUG SURVEILLANCE PROGRAM; DRUG TARGETING; LETTER; PRIORITY JOURNAL;

CARDIOVASCULAR DISEASES; COMPUTATIONAL BIOLOGY; DATA MINING; DRUG THERAPY; HUMANS; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION; SYSTEMS INTEGRATION;

EID: 84857646333     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2011.00367.x     Document Type: Letter

References (2)

1. Azuaje F, Zhang L, Devaux Y, Wagner DR. Dug-target network in myocardial infarction reveals multiple side effects of unrelated drugs. Sci Rep. 2011; 1: 52.
2. Singh S, Loke YK, Spangler JG, Furberg CD. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ 2011; 183: 1359-1366.